Year To Quarter End Consolidated Statement Of Comprehensive Income

SAPPORO CLINICAL LABORATORY INC. - Filing #7325055

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
460,452,000 JPY
362,954,000 JPY
460,452,000 JPY
460,452,000 JPY
460,452,000 JPY
471,722,000 JPY
471,722,000 JPY
471,722,000 JPY
471,722,000 JPY
640,549,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
47,702,000 JPY
8,817,000 JPY
Other comprehensive income
47,702,000 JPY
8,817,000 JPY
Comprehensive income
410,656,000 JPY
649,366,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
427,858,000 JPY
577,437,000 JPY
Comprehensive income attributable to non-controlling interests
-17,202,000 JPY
71,929,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.